Mathias Forjan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Top Venues

Acta paediatrica (Oslo, Norway : 1992)

This page only lists publications with an associated author ORCID identifier.

Publications

Richard Pasteka, Lisa Hufnagl, Mathias Forjan, Angelika Berger, Tobias Werther, Michael Wagner
Positive end-expiratory pressure and surfactant administration mode influence function in ex-vivo premature sheep lungs. Acta paediatrica (Oslo, Norway : 1992) 113 (4) (2023)
Richard Pasteka, Lisa Hufnagl, Mathias Forjan, Angelika Berger, Tobias Werther, Michael Wagner
Positive end-expiratory pressure and surfactant administration mode influence function in ex-vivo premature sheep lungs. Acta paediatrica (Oslo, Norway : 1992) (2023)
Richard Pasteka, Lisa Hufnagl, Mathias Forjan, Angelika Berger, Tobias Werther, Michael Wagner
Positive end-expiratory pressure and surfactant administration mode influence function in ex-vivo premature sheep lungs. Acta paediatrica (Oslo, Norway : 1992) 113 (4) (2023)
Richard Pasteka, Lisa Hufnagl, Mathias Forjan, Angelika Berger, Tobias Werther, Michael Wagner
Positive end-expiratory pressure and surfactant administration mode influence function in ex-vivo premature sheep lungs. Acta paediatrica (Oslo, Norway : 1992) 113 (4) (2023)
Richard Pasteka, Lara Alina Schöllbauer, Joao Pedro Santos da Costa, Radim Kolar, Mathias Forjan
Experimental Evaluation of Dry Powder Inhalers during Inhalation and Exhalation Using a Model of the Human Respiratory System (xPULM™). Pharmaceutics 14 (3) (2022)